ScholarIQanswers from OpenAlex & ORCID
Guntram Schernthaner
ResearcherPublications, citations & collaboration network
Guntram Schernthaner is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Guntram Schernthaner have?
ScholarIQindexed works
Guntram Schernthaner has 311 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Guntram Schernthaner have?
ScholarIQcitation count
Guntram Schernthaner has 21,147 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Guntram Schernthaner?
ScholarIQh-index
Guntram Schernthaner has an h-index of 70 in OpenAlex.
What is the i10-index of Guntram Schernthaner?
ScholarIQi10-index
Guntram Schernthaner has an i10-index of 180 in OpenAlex.
What is the ORCID of Guntram Schernthaner?
ScholarIQorcid
The ORCID for Guntram Schernthaner is on the source record.
What is the OpenAlex record for Guntram Schernthaner?
ScholarIQopenalex
The OpenAlex for Guntram Schernthaner is on the source record.
What are the most-cited papers on Guntram Schernthaner?
ScholarIQmost cited works
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
John Dormandy, B Charbonnel, D.J.A. Eckland, Erland Erdmann, Massimo Massi‐Benedetti, Ian K. Moules, Allan M. Skene, Meng H. Tan, Pierre J. Lefèbvre, Gordon Murray, Eberhard Standl, Robert G. Wilcox, Lars Wilhelmsen, John Betteridge, Kåre I. Birkeland, Alain Golay, Robert J. Heine, László Korányi, Markku Laakso, Marian Mokáň, Antanas Norkus, Valdis Pīrāgs, Toomas Podar, André Scheen, Werner A. Scherbaum, Guntram Schernthaner, Ole Schmitz, J Skrha, Ulf Smith, J Tatoń
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors Task Force Members, L Rydén, Eberhard Standl, M. Bartnik, Greet Van den Berghe, John Betteridge, Menko‐Jan de Boer, Francesco Cosentino, Bengt Jönsson, Markku Laakso, K. Malmberg, Silvia G. Priori, Jan Östergren, J Tuomilehto, Inga S. Þráinsdóttir, Other Contributors, Ilse Vanhorebeek, Marco Stramba‐Badiale, Peter Lindgren, Qing Qiao, Silvia G. Priori, J J Blanc, Andrzej Budaj, A. John Camm, V. Dean, Jaap W. Deckers, Kenneth Dickstein, J. Lekakis, Keith McGregor, Marco Metra, João Morais, A. Osterspey, Juan Tamargo, José Luís Zamorano, Document Reviewers, Jaap W. Deckers, M Bertrand, B Charbonnel, Erland Erdmann, Ele Ferrannini, Allan Flyvbjerg, H. Gohlke, J.R.G. Juanatey, Ian Graham, Pedro Monteiro, Klaus G. Parhofer, Kalevi Pyörälà, Itamar Raz, Guntram Schernthaner, Massimo Volpe, David M. Wood
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
J. Floege, Jae Bum Kim, Elizabeth Ireland, Charles Chazot, Tilman B. Drüeke, Angel de Francisco, Florian Kronenberg, Daniele Marcelli, Jutta Passlick‐Deetjen, Guntram Schernthaner, Bruno Fouqueray, David C. Wheeler, on behalf of the ARO Investigators
Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial
Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier, Fernando de Álvaro, Giacomo Deferrari, Gilbert M. Eisner, Enric Esmatjes, Richard E. Gilbert, Lawrence G. Hunsicker, José B. Lopes de Faria, Ruggero Mangili, Jack Moore, Efrain Reisin, Eberhard Ritz, Guntram Schernthaner, Samuel Spitalewitz, H Tindall, Roger A. Rodby, Edmund J. Lewis